Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Matinas BioPharma Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MTNB.
You can purchase shares of Matinas BioPharma Hldgs (AMEX:MTNB) through any online brokerage.
Other companies in Matinas BioPharma Hldgs’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA) and Tharimmune (NASDAQ:THAR).
Matinas BioPharma Hldgs has a consensus price target of $3.00.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.6846 last updated May 14, 2025 at 5:42 PM EDT.
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.